[{"Assets_0_Q2_USD":1751486000.0,"CommonStockSharesOutstanding_0_Q2_shares":155302753.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":5288000.0,"StockholdersEquity_0_Q2_USD":1158155000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":529792000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":304642000.0,"Ticker":"ALKS","CIK":"1520262","name":"ALKERMES PLC.","OfficialName":"Alkermes plc Ordinary Shares","form":"10-Q","period":"20180630","fy":"2018.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"4612884468.0","Country":"Ireland","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20180726"}]